支气管癌患者的抗利尿激素（作者译）
[Antidiuretic hormone in patients with bronchial carcinoma (author's transl)].
作者信息
Gropp C, Havemann K, Kalbfleisch H, Luster W, Sosstmann H
出版信息
Dtsch Med Wochenschr. 1982 Jun 25;107(25):974-7. doi: 10.1055/s-2008-1070056.
Antidiuretic hormone (ADH) was determined by radioimmunoassay in 139 patients with bronchial carcinoma. Serum ADH levels, compared with a control group, were increased in 30% of patients with small-cell and 21% of patients with large-cell bronchial carcinoma. Patients with squamous carcinoma or adenocarcinoma had normal ADH values. There was no correlation between serum ADH levels and stage of tumour. Serial ADH measurements during chemotherapy provided good correlation between ADH and response to treatment. ADH was also demonstrable by immunohistology in the tumour cells of one patient with increased serum levels.
采用放射免疫分析法对139例支气管癌患者进行了抗利尿激素（ADH）测定。与对照组相比，小细胞支气管癌患者中有30%、大细胞支气管癌患者中有21%的血清ADH水平升高。鳞状细胞癌或腺癌患者的ADH值正常。血清ADH水平与肿瘤分期之间无相关性。化疗期间连续测定ADH显示，ADH与治疗反应之间具有良好的相关性。在1例血清水平升高患者的肿瘤细胞中，通过免疫组织学方法也证实了ADH的存在。
Zotero 插件